NDAOPHTHALMICSOLUTION/DROPS
Approved
Jul 1953
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
OPHTHAINE (proparacaine hydrochloride) by Bristol Myers Squibb is clinical pharmacology proparacaine hydrochloride ophthalmic solution is a rapidly-acting topical anesthetic, with induced anesthesia lasting approximately 10-20 minutes. First approved in 1953.
Drug data last refreshed 7h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
OPHTHAINE (proparacaine hydrochloride) is a rapidly-acting topical ophthalmic anesthetic solution approved in 1953 for short-duration local anesthesia of the eye. It induces anesthesia lasting approximately 10-20 minutes, making it suitable for brief diagnostic and surgical procedures. The drug works by blocking nerve conduction in sensory nerve fibers.
LOE Approaching
As a legacy product approaching loss of exclusivity with moderate competitive pressure (30%), the brand team is likely in maintenance/transition mode with reduced headcount.
Mechanism of Action
CLINICAL PHARMACOLOGY Proparacaine hydrochloride ophthalmic solution is a rapidly-acting topical anesthetic, with induced anesthesia lasting approximately 10-20 minutes.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on OPHTHAINE offers limited high-growth career trajectory but valuable experience in legacy product management, cost optimization, and market defense in a mature therapeutic category. This role is best suited for professionals seeking stability and operational expertise rather than launch excitement or innovative development.
Brand ManagerField Sales Representative
Worked on OPHTHAINE at Bristol Myers Squibb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.